Company intelligence / Profile preview

Bioceptive

New Orleans, Louisiana, United Statesbioceptive.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bioceptive has developed a patented, FDA-cleared suction-based cervical retractor that replaces the traditional tenaculum for gynecological procedures. Clinical results indicate significant reduction in pain and improved patient experience. The company’s platform enables development of additional devices such as an advanced IUD inserter currently in preclinical testing. The technology aims to simplify transcervical access, reduce complications, expand provider access, and improve outcomes for women globally.

Therapeutic areas: Women's Health
Modalities: DeviceMedical device (specifically for gynecological procedures)
Industry: Surgical Medical Devices

Partnerships

Trimedic – joint venture to commercialize the Cervical Suction Retractor in Canada & US

Beyond the preview

Go deeper on Bioceptive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioceptive.

Explore the full profile